Sign in
4

Changes in Ownership

Vistagen Therapeutics, Inc. Filed Acc 0001415889-19-000587

Options or other derivatives

  • CHIEF MEDICAL OFFICER acquired 150,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Smith Mark Alan CHIEF MEDICAL OFFICER 2019-05-23 Grant or award · Stock Option (Right to Buy) +150,000 150,000 D
Loading xslF345X03/form4-05282019_010500.xml…